Search results for "Hepatitis C"
Did you mean "hepatitis"?
Sort by: Relevance | Newest | OldestRapid hepatitis C testing identified infections in high-risk population
Rapid testing for hepatitis C virus (HCV) at agencies for people with drug dependence identified many previously unrecognized infections, a recent study found.
https://immattersacp.org/weekly/archives/2014/04/22/4.htm
22 Apr 2014
Free CME course helps physicians identify and care for patients with liver disease
The American Association for the Study of Liver Diseases (AASLD), in collaboration with ACP, Project ECHO, the CDC, and the Department of Veterans Affairs, has developed ACT-First, a free, online CME course that will help clinicians improve their knowledge and clinical skills in hepatology.
https://immattersacp.org/weekly/archives/2014/05/20/9.htm
20 May 2014
Hepatitis C drugs offer new options
The approval of multiple drugs in 2013 and 2014 that are able to cure hepatitis C without the use of interferon has dramatically changed the screening, treatment, and epidemiologic paradigms of the virus. Soon, internists will be involved in this rapidly changing area of health care.
https://immattersacp.org/archives/2015/01/hepatitis.htm
1 Jan 2015
New meningitis vaccine, hepatitis C drug approved
Recalls and approvals.
https://immattersacp.org/archives/2015/01/fda.htm
1 Jan 2015
Hepatitis C diagnosis, treatment changing rapidly
This issue covers topics including management of hepatitis and the effect of new direct-pay practice models on primary care practice.
https://immattersacp.org/archives/2015/01/editors.htm
1 Jan 2015
Obituaries
Obituaries for Charles B. Roehrig, MD, MACP, and Charles Turner, MD, MACP, are noted.
https://immattersacp.org/archives/2015/02/obit.htm
1 Feb 2015
Letters to the Editor
Readers respond to ACP Internist coverage of issues surround the time spent with patients, ICD-10 coding changes, and physician burnout.
https://immattersacp.org/archives/2015/03/letters.htm
1 Mar 2015
New heart disease test, drugs for flu, weight management
This update covers a new test to predict risk of future coronary heart disease events, the first neuraminidase inhibitor for influenza, and a new GLP-1 agonist for obese people.
https://immattersacp.org/archives/2015/03/fda.htm
1 Mar 2015
New hepatitis C treatments cost-effective, may exceed insurers' willingness to pay
New therapies for hepatitis C are cost-effective for some patients, according to a study, but high costs may become a barrier to use.
https://immattersacp.org/weekly/archives/2015/03/31/5.htm
31 Mar 2015
Updated HIV guidelines issued
The U.S. Department of Health and Human Services issued updated guidelines April 8 on use of antiretroviral treatment in HIV-infected adults and adolescents.
https://immattersacp.org/weekly/archives/2015/04/21/5.htm
21 Apr 2015